John Segreti - Concepedia

Author

John Segreti

Rush University Medical Center

Also Known As

J Segreti, J. Segreti, Jason Segreti, John A. Segreti, John Segreti

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Rush University Medical Center Presbyterian St. Luke's Medical Center Wayne State University Henry Ford Hospital Rush University

About

John Segreti is an author at Rush University Medical Center specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	1.2K
2	Health Sciences	9	9	316
3	Public Health	4	4	244
4	Epidemiology	4	4	193
5	Emergency Medicine	1	1	120

John Segreti

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia Thomas M. File, John Segreti, L. A. Dunbar, Antimicrobial Agents and Chemotherapy	1997	365
Diagnosis of Periprosthetic Joint Infections of the Hip and Knee Craig Della Valle, Javad Parvizi, Thomas W. Bauer, Journal of the American Academy of Orthopaedic Surgeons	2010	286
Hip and Knee Section, What is the Definition of a Periprosthetic Joint Infection (PJI) of the Knee and the Hip? Can the Same Criteria be Used for Both Joints?: Proceedings of International Consensus on Orthopedic Infections Noam Shohat, Thomas W. Bauer, Martín Buttaro, The Journal of Arthroplasty International ConsensusOsteoarthritisOrthopaedicsKnee InjuriesPeriprosthetic Joint Infection	2018	260
The Importance of Long-term Acute Care Hospitals in the Regional Epidemiology of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae Michael Y. Lin, Rosie D. Lyles-Banks, Karen Lolans, Clinical Infectious Diseases	2013	228
Prolonged Suppressive Antibiotic Therapy for Infected Orthopedic Prostheses John Segreti, Jeffrey Nelson, Gordon M. Trenholme Clinical Infectious Diseases Surgical Site InfectionsAntimicrobial SusceptibilityAntibioticsAntimicrobial StewardshipAntibiotic Adjuvant	1998	197
High‐Dose Daptomycin for Treatment of Complicated Gram‐Positive Infections: A Large, Multicenter, Retrospective Study Ravina Kullar, Susan L. Davis, Donald P. Levine, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2011	133
Health Care–Associated Pneumonia (HCAP): A Critical Appraisal to Improve Identification, Management, and Outcomes—Proceedings of the HCAP Summit Marin H. Kollef, Lee E. Morrow, Robert P. Baughman, Clinical Infectious Diseases Pulmonary CareHealthcare-associated InfectionRespiratory InfectionCritical AppraisalInfection Control	2008	120
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis Ravina Kullar, Anthony M. Casapao, Susan L. Davis, Journal of Antimicrobial Chemotherapy	2013	103
Daptomycin for the Treatment of Gram‐Positive Bacteremia and Infective Endocarditis: A Retrospective Case Series of 31 Patients John Segreti, Christopher W. Crank, Michael S. Finney Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2006	86
Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections Anthony M. Casapao, Ravina Kullar, Susan L. Davis, Antimicrobial Agents and Chemotherapy	2013	84

Page 1